Money

Explained: How Pro Medicus makes its money

Add Ticker News on Google
Explained: How Pro Medicus makes its money

Pro Medicus is a Melbourne software company whose technology lets doctors view medical scans quickly. It has become one of the most valuable companies on the ASX. Here’s how it makes its money.

Pro Medicus is a health technology company based in Melbourne, and one of the most valuable technology companies on the ASX.

It was founded in 1983 by Sam Hupert and Anthony Hall, who still run the business as chief executive and technical director. Pro Medicus reports in Australian dollars, and its financial year ends on 30 June.

Visage

Its main product is Visage 7, software that lets radiologists view and analyse medical images such as MRI, CT and X-ray scans.

Modern scans create enormous files, and Visage is known for loading and displaying them very quickly, including over the internet from the cloud. That speed helps radiologists read more scans each day.

Most of Pro Medicus’s revenue comes from the U.S., where its customers include some of the country’s largest hospital systems and academic medical centres.

How it gets paid

Pro Medicus signs long-term contracts, typically five to 10 years, and is paid a fee each time a scan is read using its software, with guaranteed minimum payments. As hospitals carry out more scans, its revenue grows.

Once software is installed, adding more scans costs it very little. That means Pro Medicus keeps about three-quarters of its revenue as earnings before interest and tax, one of the highest margins of any company on the ASX.

It has no debt and pays out much of its profit as dividends.

Valuation and the risks

Because of its rapid growth and high margins, Pro Medicus’s shares trade at a very high price compared with its profits. That means even a small slowdown can cause big falls in its share price.

The risks include competition from bigger technology companies, delays in installing its software at new customers, its reliance on the U.S. market, and a stronger Australian dollar, which reduces the value of its U.S. earnings.

Latest results, as at 9 November 2026

Full year to June 2026, reported 18 August 2026: revenue rose 23 per cent to $261.7 million, and underlying profit rose 24 per cent to $144.7 million. Its earnings margin rose to 74.9 per cent. Without the impact of a stronger Australian dollar, profit would have grown about 32 per cent.

It signed 10 new contracts worth at least $407 million, including a 10-year, $170 million deal with UC Health in Colorado, and renewed all six contracts that were up for renewal. Pro Medicus paid total dividends of 69 cents a share, fully franked.

Next update: Pro Medicus reports its half-year results, to December 2026, in February 2027.

More on this story

Up next
Anthropic’s potential $60 billion IPO puts AI investment boom under scrutiny

Anthropic, the artificial intelligence company behind chatbot Claude.

Read the story →

Comments

No comments yet. Start the conversation.

Comments are checked before they appear. Keep it civil, and please don't make claims about people you can't back up.

Ticker Today takes a daily view of the world of news, politics and business.With Ahron YoungWhisky & Suits explores law, property finance and business over fine whisky.With Imran Khan and Chris ChristofiThe Founders Method explores practical lessons and systems for entrepreneursWith Jonathan Byrt and Jesse LeeworthyThe Connector explores property and urban growth across Australia and the UK.With Belinda CoateThe Property Playbook delivers research-led insights for property investors.With Tim Graham and Terry RyderState of Hospitality explores the challenges facing Australia's hospitality.With Jeremy KoadlowBuying Power helps young professionals enter property and build lasting wealth.With Victor and Reshmi KumarThe Airport Economist explores global trade, business and economic outlooks.With Tim HarcourtMedia Movers explores the trends shaping Australia's media and global news.With James ManningBroker Business explores strategies to build, grow and sustain a business.With Rex AfrasiabiMoney Matters explores practical financial strategies to build lasting wealth.With Dr Steven EnticottBeyond Education explores the ideas and technology shaping future learning.With Greg CampitelliTicker Air explores the latest aviation news, travel trends and developments.With Ahron YoungEarly Years Dialogue explores the issues shaping Australia's early learning.With Paul MondoMarkets and Machines explores AI, regulation and trends shaping the markets.With Chris BergSocial Intelligence explores how social media and AI transform our daily lives.With Dr Karen SutherlandThe AI Edge explores how artificial intelligence reshapes the world economy.With Brad Gastwirth

More from Ticker

Watch

More in Money

View all →